Human purified CD8+ T cells:: Ex vivo expansion model to generate a maximum yield of functional cytotoxic cells

被引:4
作者
Al-Shanti, Nasser
Aldahoudi, Ziyad
机构
[1] Manchester Metropolitan Univ, Inst Clin Res Human Movement, Stoke On Trent ST7 2HL, Staffs, England
[2] Kochi Univ, Sch Med, Dept Mol Genet, Kochi 780, Japan
关键词
autologous feeders; cytokines; expansion; human CD8(+) T cells;
D O I
10.1080/08820130600991950
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T cells are a critical component of the cellular immune response. They play an important role in the control of viral infection and eliminating cells with malignant potential. However, attempts to generate and expand human CD8(+) T cells in vitro for an adoptive immunotherapy have been conducted with limitation of the very low frequency of CD8(+) T cells in blood. Therefore, several expansion protocols have been developed to obtain large and efficient numbers of human CD8(+) T cells for use in adoptive immunotherapies. In this study various common culture conditions using different cytokines IL-2, IL-4, IL-7, IL-10, IL-12 and IL-15 and autologous feeders and sera were investigated to expand human purified CD8(+) T cells. The importance and the influence of these factors on the growth and phenotype of CD8(+) T cell were assessed by serially sampling cultures using flow cytometry. We demonstrated that combination of IL-2 (50U/ml) and autologous feeders induced maximal CD8(+) T cell proliferation (40-50 folds) compared to other cytokines. Immunophenotypic analysis of cultured cells showed that expanded CD8(+) T cells were activated and differentiated. Furthermore our expansion model also demonstrated that expanded CD8(+) T cells are functionally cytotoxic active by killing Allogeneic LCLs cells. In conclusion, we have developed a reliable, simple method that uses minimal cell numbers to generate a high yield of functional cytotoxic CD8(+) T cells, which can be used for the development of cellular immunotherapies.
引用
收藏
页码:85 / 104
页数:20
相关论文
共 50 条
[1]   INTERLEUKIN-7 ENHANCES CYTOLYTIC LYMPHOCYTE-T GENERATION AND INDUCES LYMPHOKINE-ACTIVATED KILLER-CELLS FROM HUMAN PERIPHERAL-BLOOD [J].
ALDERSON, MR ;
SASSENFELD, HM ;
WIDMER, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) :577-587
[2]   IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro [J].
Alves, NL ;
Hooibrink, B ;
Arosa, FA ;
van Lier, RAW .
BLOOD, 2003, 102 (07) :2541-2546
[3]  
AZUMA M, 1993, J IMMUNOL, V150, P1147
[4]   ANTITUMOR-ACTIVITY OF INTERLEUKIN-12 [J].
BRUNDA, MJ ;
GATELY, MK .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 71 (03) :253-255
[5]   Unconventional T-cell activation by IL-15 in rheumatoid arthritis [J].
Carson, DA .
NATURE MEDICINE, 1997, 3 (02) :148-149
[6]   CD57+ T-LYMPHOCYTES ARE DERIVED FROM CD57- PRECURSORS BY DIFFERENTIATION OCCURRING IN LATE IMMUNE-RESPONSES [J].
DANGEAC, AD ;
MONIER, S ;
PILLING, D ;
TRAVAGLIOENCINOZA, A ;
REME, T ;
SALMON, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) :1503-1511
[7]   New paradigm for lymphocyte granule-mediated cytotoxicity - Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis [J].
Froelich, CJ ;
Orth, K ;
Turbov, J ;
Seth, P ;
Gottlieb, R ;
Babior, B ;
Shah, GM ;
Bleackley, RC ;
Dixit, VM ;
Hanna, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29073-29079
[8]   Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus [J].
Fu, TM ;
Freed, DC ;
Trigona, WL ;
Guan, LM ;
Zhu, L ;
Long, R ;
Persaud, NV ;
Manson, K ;
Dubey, S ;
Shiver, JW .
JOURNAL OF VIROLOGY, 2001, 75 (01) :73-82
[9]   Fibroblasts prevent apoptosis of IL-2-deprived T cells without inducing proliferation: A selective effect on Bcl-x(L) expression [J].
Gombert, W ;
Borthwick, NJ ;
Wallace, DL ;
Hyde, H ;
Bofill, M ;
Pilling, D ;
Beverley, PCL ;
Janossy, G ;
Salmon, M ;
Akbar, AN .
IMMUNOLOGY, 1996, 89 (03) :397-404
[10]  
Groux H, 1998, J IMMUNOL, V160, P3188